Radiation Exposure Early in Life Can Be Reduced by Lung Ultrasound

To the Editor:
Serious concern has been raised lately about the negative effects of the ionizing irradiation exposure in diagnostic procedures (radiography, CT scan, angiography, radionuclide scan, PET scan, etc), which carries a potentially high risk for development of malignancies.
1 , 2 Moreover, precocious exposure of infants and children to radiation may lead to a higher risk of developing malignancies later in life due to both the latency of the effect of radiation exposure on the cells and the fact that growing children are inherently more radiosensitive because they have a larger proportion of dividing cells. Sick neonates, mature and premature, still are regularly exposed to serial radiographic imaging for the diagnosis of pulmonary diseases, and it is not diffi cult to calculate how many millisieverts each newborn in the neonatal ICU can accumulate during the hospitalization.
Since 2005, our group has standardized and applied an ultrasonographic diagnostic approach for the pulmonary pathology of the newborn 3 -5 according to previous experiences in adults.
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Ultrasound images of uniformly aerated lungs are not visible as real images but as artifacts that appear black with regularly distributed horizontal white artifacts (A lines) representing the visual Figure 1 . A, Normal lung of a term infant. Note the regular pleural line and the horizontal artifacts (A lines). B, The presence of vertical artifact (ULCs) expression of increased extravascular lung fl uid. C, Coalescent ULCs with echographic white-lung expression of severe alveolar interstitial syndrome due to the presence of a very high amount of lung fl uid both in the interstitium and in the alveoli. ULC 5 ultrasound lung comet.
phenomenon of reverberance of the pleura within the aerated lung ( Fig 1A ) . In the presence of fl uid in the interstitial space, in the alveoli, or in both, the artifacts are vertical (ultrasound lung comets) ( Fig 1B ) , and tend to coalesce with increasing amount of fl uid up to a totally white appearance (ultrasonographic white lung) ( Fig 1C ) . During the neonatal period, lung echography can be used to accurately diagnose transient tachypnea in the newborn, respiratory distress syndrome, atelectasis, pneumothorax, and bronchopulmonary dysplasia. 3 -5 Due to the accuracy of the diagnostic information obtained by lung echography in our institution, this method replaces radiography as the fi rst-line diagnostic approach in this age. We believe that this technique should be understood as an extension of clinical examination and should be performed by the clinicians who know what they are searching and who understand what they see.
So far, the interest of the neonatal and pediatric community of specialists toward lung ultrasound is growing very slowly. However, we strongly believe that the use of ultrasound in respiratory diseases of the newborn and the child needs to be encouraged not just as a valid diagnostic alternative but as a necessary ethical choice. of health technology by clinical staff at a health-care facility to remotely monitor a patient's progress. The ability to have surveillance of the patient's clinical data while the patient is at home is proving to be of interest to clinicians and commissioners of services. 8 However, telemonitoring in the intermediate care patient population may provide information that previously proved to be elusive to capture and could contribute to a central hub of clinical decision making.
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We recently reviewed . 1,000 articles and were able to identify a very small number of high-quality studies ( Table 1 ) that have attempted to use telemonitoring as an adjunct clinical tool within intermediate care alongside or as a comparison with "best" guideline-based practice. Many studies that we reviewed simply described the technology. Our primary outcome measures were hospital readmission rates, length of stay, unscheduled health care, and exacerbations at home, and secondary outcomes were changes in health behavior and quality of life. Our review found a lack of telemonitoring homogeneity because of the different technologies used in these studies and the fact that many studies reported high attrition rates. Of particular interest, some studies reduced readmission rates and length of stay; however, these improvements were not mirrored in positive changes in quality-of-life scores. Although it appears that several studies did seem to show a change in the number of unscheduled care events, the differing types of technology used, their monitoring schedules, patient populations, and the lack of a guideline-based best practice comparator according to the intermediate care guideline 2 brings a challenge to the clinical interpretation of these results. It has been previously noted that intermediate care may not be a suitable option for 75% of patients with COPD presenting to hospitals for assessment of an exacerbation, 13 and technology reduces this potential number of patients further. On completing this review, we fi nd it diffi cult to recommend to commissioners the addition of this technology to intermediate care and see the need for better quality studies in the future that can establish a clear role for telemonitoring as an adjunct to intermediate care.
